nirogacestat
springworks therapeutics
['defi ', 'gamma', 'springworks']
today, we announced positive data from our phase 3 defi trial evaluating our investigational gamma secretase inhibitor in patients with #desmoid tumors. read more: #esmo22 
At SpringWorks, we bring tenacity to work every day because patients need answers now.